Tandem Diabetes Care TNDM
NASDAQ TNDM
$22.67 -0.78 (-3.35%)
At close: Aug 20, 2026 · 2:30 PM UTC

Tandem Diabetes Care (TNDM) Invested Capital (2024 - 2025)

Tandem Diabetes Care's (TNDM) quarterly Invested Capital came in at $40.7 million in Q1 2025, little changed on a QoQ basis from $40.7 million in Q4 2024.

Tandem Diabetes Care (TNDM) Invested Capital (2024 - 2025) Analysis & Trends

Tandem Diabetes Care (TNDM) has 2 years of Invested Capital data on file, last reported at $40.7 million in Q1 2025.

  • Quarterly Invested Capital changed N/A year-over-year to $40.7 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $40.7 million (down 66.56% YoY) and the FY2024 annual result came in at $40.7 million, changed N/A from the prior year.
  • Invested Capital was little changed at $40.7 million in Q1 2025, from $40.7 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $40.7 million in Q1 2025 to a low of $40.5 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Abbott Laboratories 199.46 Bn 193.86 Bn 7.27 Bn 3.01 Bn
2 Stryker 127.41 Bn 123.93 Bn 4.50 Bn 750.00 Mn
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn 1.79 Bn
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn 1.71 Bn
5 Edwards Lifesciences 51.95 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.30 Bn 32.35 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn 2.00 Mn
8 Koninklijke Philips 26.35 Bn 23.02 Bn 4.55 Bn 1.34 Bn
9 Steris 23.04 Bn 22.55 Bn 684.20 Mn 243.40 Mn
10 Tandem Diabetes Care 1.56 Bn 1.11 Bn 144.78 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 40.74 Mn
Dec 31, 2024 40.67 Mn
Sep 30, 2024 40.61 Mn
Jun 30, 2024 40.54 Mn